Management and diagnostic guidelines for urticaria and angio-oedema, British Journal of Dermatology, vol.81, issue.4, pp.708-722, 2001. ,
DOI : 10.1046/j.1365-2133.1998.02175.x
Hereditary Angioedema: New Findings Concerning Symptoms, Affected Organs, and Course, The American Journal of Medicine, vol.119, issue.3, pp.267-74, 2006. ,
DOI : 10.1016/j.amjmed.2005.09.064
Deficiencies of C1 inhibitor, Best Practice & Research Clinical Gastroenterology, vol.19, issue.2, pp.251-61, 2005. ,
DOI : 10.1016/j.bpg.2004.11.011
The pathophysiology of hereditary angioedema, Clinical Immunology, vol.114, issue.1, pp.3-9, 2005. ,
DOI : 10.1016/j.clim.2004.05.007
Nonallergic angioedema: role of bradykinin, Allergy, vol.77, issue.6, pp.842-56, 2007. ,
DOI : 10.1111/j.1398-9995.2006.01197.x
The Kallikrein-Kinin System: Current and Future Pharmacological Targets, Journal of Pharmacological Sciences, vol.99, issue.1, pp.6-38, 2005. ,
DOI : 10.1254/jphs.SRJ05001X
Hereditary angio-oedema, The Lancet, vol.379, issue.9814, pp.474-81 ,
DOI : 10.1016/S0140-6736(11)60935-5
Angioedema due to acquired C1-inhibitor deficiency: A bridging condition between autoimmunity and lymphoproliferation, Autoimmunity Reviews, vol.8, issue.2, pp.156-165, 2008. ,
DOI : 10.1016/j.autrev.2008.05.003
Hereditary Angioneurotic Edema: Two Genetic Variants, Science, vol.148, issue.3672, pp.957-958, 1965. ,
DOI : 10.1126/science.148.3672.957
Angioedema Incidence in US Veterans Initiating Angiotensin-Converting Enzyme Inhibitors, Hypertension, vol.51, issue.6, pp.1624-1654, 2008. ,
DOI : 10.1161/HYPERTENSIONAHA.108.110270
Hilary J Longhurst 2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema Allergy Asthma Clin Immunol, p.24, 2010. ,
Biochemical Properties of Recombinant Prolyl Dipeptidases DPP-IV and DPP8 ,
DOI : 10.1007/0-387-32824-6_3
Mollnes Effect of supraphysiologic levels of C1-inhibitor on the classical, lectin and alternative pathways of complement, Molecular Immunology, vol.44, pp.1819-1826, 2006. ,
Agostoni Consumption of C4b-binding protein (C4BP) during in vivo activation of the classical complement pathway Clin Exp Immunol, pp.220-224, 1999. ,
Hereditary and acquired angioedema: Problems and progress: Proceedings of the third C1 esterase inhibitor deficiency workshop and beyond, Journal of Allergy and Clinical Immunology, vol.114, issue.3, pp.51-131, 2004. ,
DOI : 10.1016/j.jaci.2004.06.047
First case of homozygous C1 inhibitor deficiency, Journal of Allergy and Clinical Immunology, vol.118, issue.6, pp.1330-1335, 2006. ,
DOI : 10.1016/j.jaci.2006.07.035
Hereditary and Acquired C1-Inhibitor Deficiency, Medicine, vol.71, issue.4, pp.206-221, 1992. ,
DOI : 10.1097/00005792-199207000-00003
Hereditary Angioedema, New England Journal of Medicine, vol.359, issue.10, pp.1027-1063, 2008. ,
DOI : 10.1056/NEJMcp0803977
Acquired angioedema Allergy, Asthma & Clinical Immunology, p.14, 2010. ,
Acquired angioedema with lymphoproliferative disorder: association of C1 inhibitor deficiency with cellular abnormality, Blood, vol.48, pp.567-80, 1976. ,
Lymphoproliferative disease and acquired C1 inhibitor deficiency, Haematologica, vol.92, issue.5, pp.716-724, 2007. ,
DOI : 10.3324/haematol.10769
A case of hereditary angio-oedema type III presenting with C1-inhibitor cleavage and a missense mutation in the F12 gene, British Journal of Dermatology, vol.156, issue.5, pp.1063-1068, 2007. ,
DOI : 10.1210/en.136.11.5076
URL : https://hal.archives-ouvertes.fr/hal-00400125
Hereditary angioedema caused by missense mutations in the factor XII gene: Clinical features, trigger factors, and therapy, Journal of Allergy and Clinical Immunology, vol.124, issue.1, pp.129-163, 2009. ,
DOI : 10.1016/j.jaci.2009.03.038
Omapatrilat and enalapril in patients with hypertension: the Omapatrilat Cardiovascular Treatment vs. Enalapril (OCTAVE) trial, American Journal of Hypertension, vol.17, issue.2, pp.103-114, 2004. ,
DOI : 10.1016/j.amjhyper.2003.09.014
A Variant in XPNPEP2 Is Associated with Angioedema Induced by Angiotensin I???Converting Enzyme Inhibitors, The American Journal of Human Genetics, vol.77, issue.4, pp.617-643, 2005. ,
DOI : 10.1086/496899
Risk of angioedema with angiotensin receptor blockers in patients with prior angioedema associatedwith angiotensinconverting enzyme inhibitors: a meta-analysis, 2008. ,
Comparative Risk for Angioedema Associated With the Use of Drugs That Target the Renin-Angiotensin-Aldosterone System, Archives of Internal Medicine, vol.172, issue.20, pp.1582-1591, 2012. ,
DOI : 10.1001/2013.jamainternmed.34
The role of angiotensin receptor blockers in patients with angiotensin-converting enzyme inhibitor-induced angioedema. Ann Pharmacother, 2011. ,
The angiotensin II type 1 receptor antagonist Losartan binds and activates bradykinin B2 receptor signaling, Regulatory Peptides, vol.167, issue.1, pp.21-26, 2011. ,
DOI : 10.1016/j.regpep.2010.11.003
Losartan Increases Bradykinin Levels in Hypertensive Humans Circulation, pp.315-320, 2005. ,
Hereditary angioedema: A decade of human C1-inhibitor concentrate therapy, Journal of Allergy and Clinical Immunology, vol.120, issue.4, pp.941-948, 2007. ,
DOI : 10.1016/j.jaci.2007.06.026
-receptor antagonist icatibant, Allergy, vol.71, issue.12, pp.1490-1492, 2006. ,
DOI : 10.2165/00126839-200506040-00008
URL : https://hal.archives-ouvertes.fr/hal-01258379
Icatibant, Drugs, vol.123, issue.Suppl., pp.73-81, 2010. ,
DOI : 10.2165/11204500-000000000-00000
Icatibant, a New Bradykinin-Receptor Antagonist, in Hereditary Angioedema, WT. Icatibant, a new bradykininreceptor antagonist, pp.532-573, 2010. ,
DOI : 10.1056/NEJMoa0906393
Hereditary and Acquired C1-Inhibitor Deficiency, Medicine, vol.71, issue.4, pp.206-221, 1992. ,
DOI : 10.1097/00005792-199207000-00003
Treatment of Hereditary Angioedema with Danazol, New England Journal of Medicine, vol.295, issue.26, pp.1444-1452, 1976. ,
DOI : 10.1056/NEJM197612232952602
Increased expression of C1-inhibitor mRNA in patients with hereditary angioedema treated with Danazol, Immunology Letters, vol.86, issue.3, pp.271-277, 2003. ,
DOI : 10.1016/S0165-2478(03)00029-4
Tranexamic Acid Therapy in Hereditary Angioneurotic Edema, New England Journal of Medicine, vol.287, issue.9, pp.452-456, 1972. ,
DOI : 10.1056/NEJM197208312870907
Hereditary angiodema: a current state-of-the-art review, VII: Canadian Hungarian 2007 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary Angioedema, Annals of Allergy, Asthma & Immunology, vol.100, issue.1, pp.30-40, 2008. ,
DOI : 10.1016/S1081-1206(10)60584-4
Eradication of Helicobacter pylori and improvement of hereditary angioneurotic oedema, The Lancet, vol.358, issue.9294, pp.1695-1701, 2001. ,
DOI : 10.1016/S0140-6736(01)06720-4
2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema, International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema, p.24, 2010. ,
DOI : 10.1186/1710-1492-6-24
The humanistic burden of hereditary angioedema: Impact on health-related quality of life, productivity, and depression, Allergy and Asthma Proceedings, vol.31, issue.5, pp.407-421, 2010. ,
DOI : 10.2500/aap.2010.31.3394
Treatment of Hereditary Angioedema: items that need to be addressed in practice parameter, Allergy, Asthma & Clinical Immunology, vol.6, issue.1, p.11, 2010. ,
DOI : 10.1186/1710-1492-6-11
Intravenous tranexamic acid in the management of hereditary angio-oedema, British Journal of Oral and Maxillofacial Surgery, vol.25, issue.6 ,
DOI : 10.1016/0266-4356(87)90143-4
Tranexamic acid: Preoperative prophylactic therapy for patients with hereditary angioneurotic edema, Journal of Allergy and Clinical Immunology, vol.60, issue.1, pp.38-40, 1977. ,
DOI : 10.1016/0091-6749(77)90080-X
Characterization of acute hereditary angioedema attacks during pregnancy and breast-feeding and their treatment with C1 inhibitor concentrate, American Journal of Obstetrics and Gynecology, vol.203, issue.2, pp.131-132, 2010. ,
DOI : 10.1016/j.ajog.2010.03.003
Hereditary angioedema in pregnancy -case series study. The 6th C1-INH Defi ciency Workshop, pp.22-2458, 2009. ,
International consensus and practical guidelines on the gynecologic and obstetric management of female patients with hereditary angioedema caused by C1 inhibitor deficiency, Journal of Allergy and Clinical Immunology, vol.129, issue.2, pp.308-328, 2012. ,
DOI : 10.1016/j.jaci.2011.11.025
Disease expression in women with hereditary angioedema, American Journal of Obstetrics and Gynecology, vol.199, issue.5, pp.484-485, 2008. ,
DOI : 10.1016/j.ajog.2008.04.034
URL : https://hal.archives-ouvertes.fr/hal-00400660
Long-term follow-up of 111 patients with angiotensin-converting enzyme inhibitor-related angioedema, Journal of Hypertension, vol.29, issue.11, pp.2273-2280, 2011. ,
DOI : 10.1097/HJH.0b013e32834b4b9b
Increased Incidence of Angioedema with ACE Inhibitors in Combination with mTOR Inhibitors in Kidney Transplant Recipients, Clinical Journal of the American Society of Nephrology, vol.5, issue.4, pp.703-711 ,
DOI : 10.2215/CJN.07371009
Trends in the use of antihypertensive drugs in France from 2002 to 2012: Flahs surveys, Ann Cardiol Angeiol. Paris, vol.61, issue.3, p.218223, 2013. ,
Change in life style and drug therapy for treatment of hypertension in France between, Arch Mal Coeur, vol.98, pp.813-819, 2002. ,
Clinical Profile of Angioedema Associated With Angiotensin Converting-Enzyme Inhibition, JAMA: The Journal of the American Medical Association, vol.260, issue.7, pp.967-970, 1988. ,
DOI : 10.1001/jama.1988.03410070095035
Is there a need for clinical guidelines in the United States for the diagnosis of hereditary angioedema and the screening of family members of affected patients?, Annals of Allergy, Asthma & Immunology, vol.104, issue.3, pp.211-214, 2010. ,
DOI : 10.1016/j.anai.2009.12.004
Hereditary angioedema due to C1 inhibitor deficiency: patient registry and approach to the prevalence in Spain, Annals of Allergy, Asthma & Immunology, vol.94, issue.4, pp.498-503, 2005. ,
DOI : 10.1016/S1081-1206(10)61121-0
Primary immunodeficiency diseases in Norway, Journal of Clinical Immunology, vol.20, issue.6, pp.477-485, 2000. ,
DOI : 10.1023/A:1026416017763
Quincke's oedema or angioedema ,
Attacks of hereditary angioedema: continue to use C1 esterase inhibitor ,
Hereditary Angioedema, New England Journal of Medicine, vol.359, issue.10, pp.1027-1036, 2008. ,
DOI : 10.1056/NEJMcp0803977
Hereditary angioedema with normal C1-inhibitor activity in women, The Lancet, vol.356, issue.9225, pp.213-220, 2000. ,
DOI : 10.1016/S0140-6736(00)02483-1
Missense mutations in the coagulation factor XII (Hageman factor) gene in hereditary angioedema with normal C1 inhibitor, Biochemical and Biophysical Research Communications, vol.343, issue.4, pp.1286-1295, 2006. ,
DOI : 10.1016/j.bbrc.2006.03.092
Pediatric hereditary angioedema due to C1-inhibitor deficiency., Allergy, Asthma & Clinical Immunology, vol.6, issue.1, p.18, 2010. ,
DOI : 10.1186/1710-1492-6-18
Type III hereditary angioedema: defined, but not understood, Annals of Allergy, Asthma & Immunology, vol.109, issue.3, pp.153-157, 2012. ,
DOI : 10.1016/j.anai.2012.07.007
Hereditary Angioedema with Normal C1 Inhibitor: Clinical Symptoms and Course, The American Journal of Medicine, vol.120, issue.11, pp.987-992, 2007. ,
DOI : 10.1016/j.amjmed.2007.08.021
Type I hereditary angio-oedema. Variability of clinical presentation and course within two large kindreds, Journal of Internal Medicine, vol.241, issue.1, pp.39-46, 1997. ,
DOI : 10.1046/j.1365-2796.1997.76893000.x
Angies hitaire par dicit en C1-inh : expression pathologique partir d'une sie de 180 patients La Revue de Médecine Interne, 2008. ,
Concerning the acute localized oedema of the skin, Monatsh Prakt Dermat, vol.I, pp.129-160, 1882. ,
HEREDITARY ANGIO-NEUROTIC ??DEMA, The American Journal of the Medical Sciences, vol.95, issue.4, pp.362-369, 1888. ,
DOI : 10.1097/00000441-188804000-00004
Plamsa bradykinin in angio-edema. Lancet, pp.1693-1700, 1998. ,
Visualisation of tissue kallikrein, kininogen and kinin receptors in human skin following trauma and in dermal diseases, Biological Chemistry, vol.385, issue.11, pp.1069-76, 2004. ,
DOI : 10.1515/BC.2004.138
Helicobacter pylori Infection as a Triggering Factor of Attacks in Patients with Hereditary Angioedema, Helicobacter, vol.89, issue.3, pp.251-258, 2007. ,
DOI : 10.1002/pmic.200401094
Angioedema without urticaria: a large clinical survey, Canadian Medical Association Journal, vol.175, issue.9, pp.1065-70, 2006. ,
DOI : 10.1503/cmaj.060535
A functional XPNPEP2 promoter haplotype leads to reduced plasma aminopeptidase P and increased risk of ACE inhibitor-induced angioedema, Human Mutation, vol.23, issue.11, pp.1326-1357, 2011. ,
DOI : 10.1002/humu.21579
Receptor Polymorphisms and ACE Activity With ACE Inhibitor-Induced Angioedema in Black and Mixed-Race South Africans, The Journal of Clinical Hypertension, vol.68, issue.6, pp.413-422, 2013. ,
DOI : 10.1111/jch.12104
The Renin-Angiotensin Aldosterone System: Pathophysiological Role and Pharmacologic Inhibition, Journal of Managed Care Pharmacy, vol.13, issue.8 Supp B, pp.9-20, 2007. ,
DOI : 10.18553/jmcp.2007.13.s8-b.9
Angiotensin-converting enzyme inhibitorinduced angioedema, Cutis. Review, vol.91, issue.1, pp.30-35, 2013. ,
Meta-Analysis of Randomized Trials of Angioedema as an Adverse Event of Renin???Angiotensin System Inhibitors, The American Journal of Cardiology, vol.110, issue.3, pp.383-391, 2012. ,
DOI : 10.1016/j.amjcard.2012.03.034
Diagnosis and treatment of hereditary angioedema with normal C1 inhibitor, Allergy, Asthma & Clinical Immunology, vol.6, issue.1, p.15, 2010. ,
DOI : 10.1186/1710-1492-6-15
Drug-induced angioedema: experience of Italian emergency departments, Internal and Emergency Medicine, vol.70, issue.1664, 2009. ,
DOI : 10.1007/s11739-013-1007-x
Factors associated with hospitalization of patients with angiotensin-converting enzyme inhibitorinduced angioedema. Allergy Asthma Proc, 2013. ,
Association of angiotensin-converting enzyme inhibitor-associated angioedema with transplant and immunosuppressant use, Allergy, vol.54, issue.Pt 1, pp.1381-1388, 2010. ,
DOI : 10.1111/j.1398-9995.2010.02398.x
Angio-??d??mes et inhibiteurs de l'enzyme de conversion de l'angiotensine??: ?? propos de 19??cas, La Revue de M??decine Interne, vol.25, issue.7, pp.501-507, 2004. ,
DOI : 10.1016/j.revmed.2004.02.024
Angioedema due to angiotensin-converting enzyme inhibitors, Immunopharmacology, vol.44, issue.1-2, pp.21-26, 1999. ,
DOI : 10.1016/S0162-3109(99)00107-1
Angioedema Associated With Angiotensin-Converting Enzyme Inhibitor Use, Archives of Internal Medicine, vol.164, issue.8, pp.910-913, 2004. ,
DOI : 10.1001/archinte.164.8.910
Clinical Profile of Angioedema Associated With Angiotensin Converting-Enzyme Inhibition, JAMA: The Journal of the American Medical Association, vol.260, issue.7, pp.967-970, 1988. ,
DOI : 10.1001/jama.1988.03410070095035
Onset of orolingual angioedema after treatment of acute brain ischemia with alteplase depends on the site of brain Ischemia: A meta-analysis, North American Journal of Medical Sciences, vol.5, issue.10, pp.589-93, 1947. ,
DOI : 10.4103/1947-2714.120794
Orolingual angioedema as complication after rtPA in stroke patient treated with ACE inhibitor, Rinsho Shinkeigaku, vol.48, p.27880, 2008. ,
Biochemical Basis of Angioedema Associated With Recombinant Tissue Plasminogen Activator Treatment: An In Vitro Experimental Approach, Stroke, vol.33, issue.6, p.17126, 2002. ,
DOI : 10.1161/01.STR.0000017284.77838.87
Dipeptidyl Peptidase-IV Inhibitor Use Associated With Increased Risk of ACE Inhibitor-Associated Angioedema, Hypertension, vol.54, issue.3, pp.516-539, 2009. ,
DOI : 10.1161/HYPERTENSIONAHA.109.134197
Angiotensin converting enzyme inhibitor-induced angioedema more prevalent in transplant patients, Annals of Allergy, Asthma & Immunology, vol.82, issue.5, pp.473-476, 1999. ,
DOI : 10.1016/S1081-1206(10)62723-8
Association of angiotensin-converting enzyme inhibitor-associated angioedema with transplant and immunosuppressant use, Allergy, vol.54, issue.Pt 1, pp.1381-1388, 2010. ,
DOI : 10.1111/j.1398-9995.2010.02398.x
Sirolimus and angiotensin-converting enzyme inhibitors together induce tongue oedema in renal transplant recipients, Nephrology Dialysis Transplantation, vol.19, issue.11, pp.2906-2908, 2004. ,
DOI : 10.1093/ndt/gfh352
Angioedema in pediatric liver transplant recipients under tacrolimus immunosuppression, Transplantation, vol.75, issue.1, pp.152-155, 2003. ,
DOI : 10.1097/00007890-200301150-00027
Serum dipeptidyl peptidase IV activity in transplant recipients, Clin Chem, vol.36, p.984, 1990. ,
Meta-Analysis of Randomized Trials of Angioedema as an Adverse Event of Renin???Angiotensin System Inhibitors, The American Journal of Cardiology, vol.110, issue.3, pp.383-391, 2012. ,
DOI : 10.1016/j.amjcard.2012.03.034
Hereditary Angioedema with Normal C1 Inhibitor: Clinical Symptoms and Course, The American Journal of Medicine, vol.120, issue.11, pp.987-992, 2007. ,
DOI : 10.1016/j.amjmed.2007.08.021
Angiotensin-Converting Enzyme (ACE) Inhibitor Angioedema: The Silent Epidemic, The American Journal of Cardiology, vol.109, issue.5, pp.774-779, 2012. ,
DOI : 10.1016/j.amjcard.2011.11.014
Treatment of angiotensin-converting enzyme inhibitor???related angioedema with the bradykinin B2 receptor antagonist icatibant, Journal of the American Academy of Dermatology, vol.63, issue.5, pp.913-917, 2010. ,
DOI : 10.1016/j.jaad.2010.03.023
Therapeutic Efficacy of Icatibant in Angioedema Induced by Angiotensin-Converting Enzyme Inhibitors: A Case Series, Annals of Emergency Medicine, vol.56, issue.3, pp.278-82, 2010. ,
DOI : 10.1016/j.annemergmed.2010.03.032
Icatibant: a novel approach to the treatment of angioedema related to the use of angiotensin-converting enzyme inhibitors, The American Journal of Emergency Medicine, vol.30, issue.8, 2011. ,
DOI : 10.1016/j.ajem.2011.09.014
L???angi??d??me laryng?? induit par les m??dicaments interf??rant avec le m??tabolisme de la bradykinine, Revue Fran??aise d'Allergologie, vol.52, issue.3, pp.157-166, 2012. ,
DOI : 10.1016/j.reval.2012.01.006
Angio-??d??me acquis induit par les IEC??: traitement aux urgences par concentr?? de C1 inhibiteur, La Revue de M??decine Interne, vol.29, issue.6, pp.516-525, 2007. ,
DOI : 10.1016/j.revmed.2007.09.038
Angioedema from angiotensin-converting enzyme (ACE) inhibitor treated with complement 1 (C1) inhibitor concentrate, Acta Anaesthesiologica Scandinavica, vol.5, issue.Suppl. 1, pp.120-122, 2006. ,
DOI : 10.1111/j.1399-6576.2005.00819.x
ACE-inhibitor induced angio-oedema treated with complement C1-inhibitor concentrate, Case Reports, vol.2013, issue.oct04 1, 2013. ,
DOI : 10.1136/bcr-2013-200652
Antihistamine-resistant Angioedema in Women with Negative Family History: Estrogens and F12 Gene Mutations, The American Journal of Medicine, vol.126, issue.12, pp.1142-1151, 2013. ,
DOI : 10.1016/j.amjmed.2013.05.017
Hereditary and Acquired C1-Inhibitor Deficiency, Medicine, vol.71, issue.4, pp.206-215, 1992. ,
DOI : 10.1097/00005792-199207000-00003
French National Reference Center for Hereditary Angioedema (CREAK).Hereditary angioedema with C1 inhibitor deficiency: clinical presentation and quality of life of 193 French patients, Ann Allergy Asthma Immunol, 2013. ,
Disease expression in women with hereditary angio-oedema, Am J Obstet Gynaecol, vol.199, p.484, 2008. ,
Type I hereditary angio-oedema. Variability of clinical presentation and course within two large kindreds, Journal of Internal Medicine, vol.241, issue.1, pp.39-46, 1997. ,
DOI : 10.1046/j.1365-2796.1997.76893000.x
Clinical, biochemical, and genetic characterization of a novel estrogen-dependent inherited form of angioedema, Journal of Allergy and Clinical Immunology, vol.106, issue.3, pp.546-550, 2000. ,
DOI : 10.1067/mai.2000.108106
Hereditary angioedema type III: An additional French pedigree with autosomal dominant transmission, Journal of Allergy and Clinical Immunology, vol.107, issue.4, pp.747-748, 2001. ,
DOI : 10.1067/mai.2001.114242
Increased Activity of Coagulation Factor XII (Hageman Factor) Causes Hereditary Angioedema Type III, The American Journal of Human Genetics, vol.79, issue.6, pp.1098-1104, 2006. ,
DOI : 10.1086/509899
URL : https://hal.archives-ouvertes.fr/hal-00399574
Hereditary angioedema caused by the p.Thr309Lys mutation in the F12 gene: A??multifactorial disease, Journal of Allergy and Clinical Immunology, vol.132, issue.4, pp.986-995, 2013. ,
DOI : 10.1016/j.jaci.2013.04.032
Antihistamine-resistant Angioedema in Women with Negative Family History: Estrogens and F12 Gene Mutations, The American Journal of Medicine, vol.126, issue.12, pp.1142-1151, 2013. ,
DOI : 10.1016/j.amjmed.2013.05.017
Mast Cells Increase Vascular Permeability by Heparin-Initiated Bradykinin Formation In??Vivo, Immunity, vol.34, issue.2, pp.258-68, 2011. ,
DOI : 10.1016/j.immuni.2011.02.008
In vivo roles of factor XII, vivoroles of factor XII, pp.4296-303, 2012. ,
DOI : 10.1182/blood-2012-07-292094
Mercè Corominas Treatment of Idiopathic Nonhistaminergic Angiodema with Icatibant World Allergy Organ J, p.46, 2012. ,
Hereditary and acquired angioedema: Problems and progress: Proceedings of the third C1 esterase inhibitor deficiency workshop and beyond, MD Hereditary and acquired angioedema: Problems and progress: Proceedings of the third C1 esterase inhibitor deficiency workshop and beyond, pp.51-131, 2003. ,
DOI : 10.1016/j.jaci.2004.06.047
Bouillet Type III hereditary angio-oedema: clinical and biological features in a French cohort, Allergy, vol.65, issue.10, pp.1331-1337, 2010. ,
Hereditary Angioedema, New England Journal of Medicine, vol.359, issue.10, pp.1027-1036, 2008. ,
DOI : 10.1056/NEJMcp0803977
Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks, Journal of Allergy and Clinical Immunology, vol.124, issue.4, pp.801-808, 2009. ,
DOI : 10.1016/j.jaci.2009.07.017
Icatibant, a New Bradykinin-Receptor Antagonist, in Hereditary Angioedema, New England Journal of Medicine, vol.363, issue.6, pp.532-541, 2010. ,
DOI : 10.1056/NEJMoa0906393
Randomized placebo-controlled trial of the bradykinin B2 receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: the FAST-3 trial, Annals of Allergy, Asthma & Immunology, vol.107, issue.6, pp.529-537, 2011. ,
DOI : 10.1016/j.anai.2011.08.015
Gompel Benefits of progestin contraception in non-allergic angioedema, Clin Exp Allergy.2013, vol.43, issue.4, pp.475-82 ,
Malbrán Open-label, multicenter study of self-administered icatibant for attacks of hereditary angioedema, Allergy, 2013. ,
Angioedema, Journal of the American Academy of Dermatology, vol.53, issue.3, pp.373-88, 2005. ,
DOI : 10.1016/j.jaad.2004.09.032
Physical urticaria. Curr Allergy Asthma Rep, 2012. ,
Episodic Angioedema Associated with Eosinophilia, New England Journal of Medicine, vol.310, issue.25, pp.1621-1627, 1984. ,
DOI : 10.1056/NEJM198406213102501
An overview of delayed pressure urticaria with special emphasis on pathogenesis and treatmentd Dermatol Ther, pp.22-28, 2009. ,
Hypocomplementemia with cutaneous vasculitis and arthritis, Mayo Clin Proc, vol.48, pp.340-348, 1973. ,
Urticaria, deafness, and amyloidosis: a new heredofamilial syndrome, The Quarterly journal of medicine, vol.31, pp.235-248, 1962. ,
Schnitzler Syndrome: Beyond the Case Reports: Review and Follow-Up of 94 Patients with an Emphasis on Prognosis and Treatment, Seminars in Arthritis and Rheumatism, vol.37, issue.3, pp.137-148, 2007. ,
DOI : 10.1016/j.semarthrit.2007.04.001
Epirubicin combined with estramustine phosphate in hormone-resistant prostate cancer: a phase II study, British Journal of Cancer, vol.76, issue.1, pp.93-99, 1997. ,
DOI : 10.1038/bjc.1997.342
Tamoxifen contraindicated in women with hereditary angioedema?, Annals of Oncology, vol.20, issue.7, pp.1281-1286, 2009. ,
DOI : 10.1093/annonc/mdp295
Recurrent angioedema associated with hypogonadism or anti-androgen therapy, Ann Allergy, vol.63, issue.4, pp.301-306, 1989. ,
In vitro comparison of bradykinin degradation by aliskiren, a renine inhibitor versus an inhibitor of angiotensine converting enzyme, J Renin Angiotensin Aldosterone Syst, 2013. ,
Aliskiren increases bradykinin and tissue kallikrein mRNA levels in the heart, Clinical and Experimental Pharmacology and Physiology, vol.278, issue.Suppl. 1, pp.623-654, 2011. ,
DOI : 10.1111/j.1440-1681.2011.05572.x
Pharmacovigilance analysis of adverse event reports for aliskiren hemifumarate, a first-in-class direct renin inhibitor, Therapeutics and Clinical Risk Management, vol.7, pp.337-381, 2009. ,
DOI : 10.2147/TCRM.S23889
Substrate specificity and inhibition of human kallikrein-related peptidase 3 (KLK3 or PSA) activated with sodium citrate and glycosaminoglycans, Archives of Biochemistry and Biophysics, vol.498, issue.1, pp.74-82, 2010. ,
DOI : 10.1016/j.abb.2010.03.022
Targeting kallikrein-related peptidases in prostate cancer, Expert Opinion on Therapeutic Targets, vol.6, issue.4, pp.365-83 ,
DOI : 10.1002/pros.22667
Repeat treatment with icatibant for multiple hereditary angioedema attacks: FAST-2 open-label study, Allergy, vol.67, issue.11, pp.1452-1461, 2013. ,
DOI : 10.1111/all.12244
WAO Guideline for the Management of Hereditary Angioedema, World Allergy Organization Journal, vol.5, issue.12, pp.182-99, 2012. ,
DOI : 10.1097/WOX.0b013e318279affa
Bradykinin and the pathophysiology of angioedema, International Immunopharmacology, vol.3, issue.3, pp.311-317, 2003. ,
DOI : 10.1016/S1567-5769(02)00162-5
Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group, Allergy, vol.6, issue.Suppl 3, 2014. ,
DOI : 10.1111/all.12380
A new case of homozygous C1-inhibitor deficiency suggests a role for Arg378 in the control of kinin pathway activation, Journal of Allergy and Clinical Immunology, vol.126, issue.6, pp.1307-1310, 2010. ,
DOI : 10.1016/j.jaci.2010.07.037
First case of homozygous C1 inhibitor deficiency, Journal of Allergy and Clinical Immunology, vol.118, issue.6, pp.1330-1335, 2006. ,
DOI : 10.1016/j.jaci.2006.07.035
De novo homozygous mutation of the C1 inhibitor gene in a patient with hereditary angioedema, Journal of Allergy and Clinical Immunology, vol.132, issue.3, pp.748-750, 2013. ,
DOI : 10.1016/j.jaci.2013.04.006